Neurology, , Amy Zarrin - Docmatcher

Match your way to better health

Advanced Search>

My Account

Log on or Register Here

Search results

Amy Zarrin Specialty: Neurology State: I'm currently: Available

My Practice My Qualifications About Me Book Appointment Send Message Forms

Office #1
Practice Setting	: Group Practice
Name of Practice	: New York Methodist Neurosciences Department
Address	: 263 7th Avenue, Suite 4 A
City	: Brooklyn
State	: New York
Zip	: 11215 Map this Address Get directions
Telephone	: 718-246-8590
Website	:www.nym.org
Wheelchair Access	: Yes
Wheelchair Detail	: Elevator
Language Speak	: English
Language support	: English, American Sign Language, Cantonese, Fijian Hindi, Filipino, French, German, Greek, Haitian Creole, Hebrew, Hindi, Indonesian, Italian, Japanese, Jewish, Patois, Portuguese, Punjabi, Russian, Slovak, Spanish, Turkish, Urdu, Vietnamese, Yiddish
How language support	: Language Line
Special Service	: General Neurologic Disease, Electrodiagnostic Medicine (EMG) and neurodiagnostics, nueuromuscular diseases.

Other Staff in Practice (Office # 1)
Name	: Jeffery Benjamin
Specialty	: Neurology

Other Staff in Practice (Office # 1)
Name	: Sagarika Nallu
Specialty	: Neurology

Insurance

: Call for insurance eligibility

Office Timing (Office #1)

Morning

Evening

Peak Times

Start

Monday

09:00 AM 05:00 PM

00:00 PM 00:00 PM

Tuesday

09:00 AM 05:00 PM

00:00 PM 00:00 PM

Wednesday

09:00 AM 05:00 PM

00:00 PM 00:00 PM

Thursday

09:00 AM 05:00 PM

00:00 PM 00:00 PM

Friday

09:00 AM 05:00 PM

00:00 PM 00:00 PM

Saturday

Off

Sunday

Off

Specialty	: Neurology;Neurology
SubSpecialty	: Neurophysiologist/EEG;Neuromuscular Medicine
Special Disease Interest	: Neuromuscular disease, EMG, nerve injuries
Other Proficiencies or Unique Services	: On-site EMG studies, Nerve Conduction Studies, Lumbar Puncture
Year of Experience	: 3

Hospital Affiliations #1

Faculty Appointment	: Co-Director Neuromuscular Program and Attending Physician
Hospital Name	: New York Methodist Hospital
Address	: 506 6th Street
City	: Brooklyn
State	: New York
Zip Code	: 11215
Tel	: 718-246-8590
Website	: www.nym.org

Education #1

Residency	: Neurology
Hospital Name	: Beth Israel Deaconess Medical Center
City	: Boston
State	: Massachusetts
Year of Graduation	: 2007

Fellowship #1

Fellowship	: Neurophysiologist/EEG
Hospital Name	: Beth Israel Deaconess Medical Center
City	: Boston
State	: Massachusetts
Year of Graduation	: 2008

Graduate Education

Degree	: PhD
Name of Institution	: Washington University School of Medicine
City	: Saint Louis
State	: Missouri

Internship

Residency	: Internal Medicine
Hospital Name	: Beth Israel Deaconess Medical Center
City	: Boston
State	: Massachusetts
Year of Graduation	: 2004

Medical/Dental School

Degree	: M.D.
Hospital Name	: Washington University School of Medicine
City	: Saint Louis
State	: Missouri
Country	: United States
Year of Graduation	: 2003

Undergraduate Education #1

Degree	: B.S.
Name of Institution	: Cornell University
City	: Ithaca
State	: New York

Other Specialty Training #1

Type of Training

: Clinical Neurophysiology

Research

Title	: Effect of newly proposed CK reference limits on neuromuscular diagnosis
Journal	: Muscle and Nerve
Year of Publication	: 2009
Article	: The objective was to determine the effect of a proposed increase in the upper reference limits of serum creatine kinase (CK) on neuromuscular disease diagnosis. This was a retrospective study of 94 Caucasian subjects (49 women and 45 men) in whom a neuromuscular physician ordered a CK as part of their evaluation. The patients were divided into two groups: those with diagnoses that either should or could elevate serum CK, and those with diagnoses that should not elevate serum CK. Sensitivities and specificities of the manufacturer's and the newly proposed upper reference limits were determined. For women, raising the upper reference limit of CK from 140 IU/L to 201 IU/L reduced the sensitivity of the test from 50% to 29%, while increasing the specificity from 67% to 80%. For men, raising the upper reference limit of CK from 174 IU/L to 322 IU/L reduced the sensitivity from 80% to 60%, while increasing the specificity from 63% to 80%. The newly proposed upper reference limits resulted in a false-negative CK of clinical significance in 7 of 94 subjects. Increasing the upper reference limit for CK reduced the sensitivity and increased the specificity of serum CK for neuromuscular disease diagnosis. Such a change will reduce unnecessary referrals and invasive diagnostic testing in patients with asymptomatic CK elevations. The clinical impact of the loss in sensitivity is small. If these new upper reference limits are adopted, neuromuscular physicians should be aware that a normal CK level does not exclude a diagnosis of myopathy.

Go back to search page

FAQs

Site map